Nebil BAL, Tahsin TURUNÇ, Alaaddin AKAY, Çetin Levent PEŞKİRCİOĞLU, Eray HASIRCI, Hüseyin ÇELİK

Expression of maspin in testis tumors with germ cells and its relation with angiogenesis factors

Background/aim: We aimed to evaluate the importance of maspin expression in testicular tumors with germ cells, its effect on prognosis, and the relation with angiogenesis factors. Materials and methods: The paraffin blocks of the orchiectomy materials of 32 patients who had undergone orchiectomy due to testicular tumors were taken within the scope of the study. The specimens of the cases included in the study group were reexamined under light microscope. Results: While just one maspin-positive sample was found in the seminoma cases, maspin stained positively in 6 of the nonseminoma germ cell tumors (NSGCTs). No statistical difference was found between maspin and tumor stage, size, alpha fetoprotein values, vascular endothelial growth factor, Ki-67, and CD31. A statistically positive correlation was only determined between maspin and p53 (P < 0.001). Conclusion: Maspin protein, whose expression in some tumors is accepted as a poor prognostic factor, is also expressed in testicular tumors with germ cells. However, according to our study, it is difficult to say whether this protein is a favorable or poor prognostic factor in testicular tumors and to understand how the effect mechanism works. The positive correlation between maspin and p53 in the NSGCTs makes us think that maspin might have displayed an effect on the p53 pathway.

PDF

___

1. Zou Z, Anisowich A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Maspin a serpin with tumorsuppressing activity in human mammary epithelial cells. Science 1994; 263: 526-529.
2. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006; 209: 617-624.
3. Sood AK, Fletcher MS, Gruman LM, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002; 8: 2924-2932.
4. Bailey CM, Khalkhali-Ellis Z, Kondo S, Margaryan NV, Seftor RE, Wheaton WW, Amir S, Pins MR, Schutte BC, Hendrix MJ. Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J Biol Chem 2005; 7: 34210-34217.
5. Hall DC, Johnson-Pais TL, Grubbs B, Bernal R, Leach RJ, Padalecki SS. Maspin reduces prostate cancer metastasis to bone. Urol Oncol 2008; 26: 652-658.
6. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.
7. Turunc T, Bal N, Dirim A, Kuzgunbay B, Gul U, Ozkardes H. Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters. Urology 2010; 76: 765.e8- 765.e13.
8. Askew YS, Pak SC, Luke CJ, Askew DJ, Cataltepe S, Mills DR, Kato H, Lehoczky J, Dewar K, Birren B et al. SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases. J Biol Chem 2001; 276: 49320-49330.
9. Marioni G, Blandamura S, Giacomelli L, Calgaro N, Segato P, Leo G, Fischetto D, Staffieri A, de Filippis C. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Histopathology 2005; 46: 576- 582.
10. Albers P, Albrecht W, Algaba F, Bokemeyer C, CohnCedermark G, Fizazi K, Horwich A, Laguna MP; European Association of Urology. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319.
11. Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H, Tanaka F. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006; 13: 1517-1523.
12. Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Pathol Res Pract 2008; 204: 379-387.
13. Lonardo F, Li X, Siddiq F, Al-Abbadi M, Pass Hi, Sheng S. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006; 51: 31-39.
14. Kazmierczak E, Grajek S, Kowal J, Chmara E, Grygier M, Pyda M, Bogdanski P, Cieslewicz A, Jablecka A. Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents. Eur Rev Med Pharmacol Sci 2014; 15: 2169-2175.
15. Fukuda S, Shirahama T, Imazono Y, Tsushima T, Ohmori H, Kayajima T, Take S, Nishiyama K, Yonezawa S, Akiba S et al. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer 1999; 85: 1323-1330.
16. Heidenreich A, Schenkmann NS, Sesterhenn IA, Mostofi FK, Mccarthy WF, Heidenreich B, Moul JW. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. J Urol 1997; 158: 620-625.
17. Düe W, Dieckmann KP, Loy V. Immunohistological determination of proliferative activity in seminomas. J Clin Oncol 1988; 41: 304-307.
18. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-456.
19. Bostwick DG, Qian J. Bladder. In: Dabbs DJ, editor. Diagnostic Immunohistochemistry. 2nd ed. St Louis, MO, USA: Elsevier Churchill Livingstone; 2006. pp. 556-558.
20. Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werner M, Jonas U. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis. Cancer 1996; 78: 1958- 1966.
21. Chresta CM, Masters JRW, Hickman JA. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res 1996; 56: 1834-1841.
22. Yilmazer D, Han U, Onal B. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 2007; 39: 691-698.